Core 001 - Virology Core
核心 001 - 病毒学核心
基本信息
- 批准号:10428298
- 负责人:
- 金额:$ 35.42万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-02-01 至 2027-01-31
- 项目状态:未结题
- 来源:
- 关键词:AnimalsAntibodiesAntibody ResponseAntibody SpecificityAntibody titer measurementAntigensB-LymphocytesBiological AssayBlood specimenCell SurvivalCollectionComplexCost efficiencyDataDatabasesEnsureEnzyme-Linked Immunosorbent AssayFoundationsFreezingGlycoproteinsGoalsHepatitis C AntibodiesHepatitis C VaccineHepatitis C virusHumanImmunizeImmunology procedureInternationalLawsLeadLibrariesLiquid substanceMacacaMethodsMonitorMusNitrogenPeer ReviewPeripheral Blood Mononuclear CellPlasmaPlasmablastPrimatesProceduresProcessProgram Research Project GrantsProtocols documentationPublicationsQuality ControlReagentRecombinantsReproducibilityReproducibility of ResultsResearchResearch PersonnelResearch Project GrantsResourcesRunningSamplingShipsStandardizationStructureSystemTimeVaccine AntigenVaccine ResearchVirusWestern BlottingWorkdata qualitydesignexperimental studyimprovedmembermutantneutralizing antibodyprogramsresponsesynergismvaccine developmentvaccine trialvirology
项目摘要
PROJECT SUMMARY
Core B Virology will serve as a centralized research resources to facilitate the research objectives of this P01
program. The functions of Core B include (1) collect and develop a library of HCV research reagents and
maintain their supply for the program; (2) perform standardized assays for quality-control of HCV antigens,
measurement of antibody titers and virus neutralizing activities, to ensure consistent and reproducibility of
experimental results; (3) processing animal samples for downstream experiments; (4) develop and document
standardized research reagents and assays to accelerate HCV vaccine development. Core B Virology will
improve cost efficiency, data quality and synergy of the research projects and cores of the P01 program.
项目摘要
核心B病毒学将作为集中研究资源,以促进本P01的研究目标
程序.核心B的功能包括:(1)收集和开发HCV研究试剂库,
维持其对该计划的供应;(2)进行HCV抗原质量控制的标准化测定,
抗体滴度和病毒中和活性的测量,以确保
实验结果;(3)处理动物样品用于下游实验;(4)开发和记录
标准化的研究试剂和检测方法,以加速HCV疫苗的开发。核心B病毒学将
提高成本效益,数据质量和研究项目的协同作用和P01计划的核心。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mansun Law其他文献
Mansun Law的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mansun Law', 18)}}的其他基金
Understanding human antibody responses to chronic viral hepatitis C
了解人类抗体对慢性丙型病毒性肝炎的反应
- 批准号:
10551237 - 财政年份:2022
- 资助金额:
$ 35.42万 - 项目类别:
Understanding human antibody responses to chronic viral hepatitis C
了解人类抗体对慢性丙型病毒性肝炎的反应
- 批准号:
10435356 - 财政年份:2022
- 资助金额:
$ 35.42万 - 项目类别:
Rheumatoid factor and cryoglobulinemia in chronic viral infection
慢性病毒感染中的类风湿因子和冷球蛋白血症
- 批准号:
9896553 - 财政年份:2019
- 资助金额:
$ 35.42万 - 项目类别:
Cooperative Center for the study of HCV antibody responses and vaccine antigens
HCV抗体反应和疫苗抗原研究合作中心
- 批准号:
9248879 - 财政年份:2016
- 资助金额:
$ 35.42万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 35.42万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 35.42万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 35.42万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 35.42万 - 项目类别:
Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 35.42万 - 项目类别:
Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 35.42万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 35.42万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
- 批准号:
10639161 - 财政年份:2023
- 资助金额:
$ 35.42万 - 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
- 批准号:
10752441 - 财政年份:2023
- 资助金额:
$ 35.42万 - 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
- 批准号:
10867639 - 财政年份:2023
- 资助金额:
$ 35.42万 - 项目类别:














{{item.name}}会员




